Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Gastroenterology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Gastric Bypass More Effective Than Sleeve for Reflux Relief
April 2025
While both bariatric surgeries aid weight loss and quality of life, Roux-en-Y gastric bypass shows greater benefits for reducing acid reflux and oesophageal inflammation.
Read more
28 Jul 2017
Why the Doctors’ Mantra Is Killing Them
It’s a deadly secret that many of us keep inside. It’s a burden that only we can feel, while acting completely unaffected to the outside world.
18 Jul 2017
RedHill Biopharma Announces Last Patient Visit in BEKINDA® Phase II Study for IBS-D
Tel-Aviv, Israel / Raleigh, NC, USA, 17 July, 2017 – RedHill Biopharma Ltd. (NASDAQ: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”)…
12 Jul 2017
RedHill Biopharma Announces Expected Timeline for DSMB Meeting and Provides Update on Enrollment in the RHB-104 Phase III Study for Crohn’s Disease
Tel-Aviv, Israel / Raleigh, NC, USA, 12 July, 2017 – RedHill Biopharma Ltd. (NASDAQ: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”)…
3 Jul 2017
Key to Preventing Listeriosis Found in Gut Microbiome
BACTERIA discovered in the gut could prove invaluable for preventing Listeria infection, according to a new study from researchers at the Memorial Sloan…
3 Jul 2017
Protein Suppression Halts the Development of Pancreatic Cancer
SUPPRESSING a specific protein could be an effective way of combatting pancreatic cancer, according to a new study performed by researchers from the Keck…
14 Jun 2017
RedHill Biopharma Announces Successful Phase III Top-Line Results with BEKINDA® for Acute Gastroenteritis
Tel-Aviv, Israel, Raleigh, USA, 14 June, 2017 – RedHill Biopharma Ltd. (NASDAQ: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”)…
19 May 2017
Child Safety Risk as Three Quarters of Paediatric IBD Patients Not Meeting Recommended Calcium and Vitamin D Intake
A new study highlights that children suffering from IBD are not meeting the daily recommended intake of calcium and vitamin D.
14 May 2017
Study Identifies a New Test to Predict Severity of Inflammatory Bowel Disease in Children
Prague, 13 May, 2017 – The results from a Norwegian study show that a new genetic test for characterising intestinal microbiota may help to diagnose…
Loading posts...
« Previous
1
…
25
26
27
28
29
…
33
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View